Editorial: The role of maintenance therapy (immunotherapy, targeted therapy, etc) in cancer control and biologic behavior of recurrent/metastatic cervical cancer

被引：0
作者：
Li, Xiaolin [1 ]
Zhang, Xianzheng [2 ]
Li, Aihua [3 ]
Xie, Peng [1 ,4 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Dept Radiat Oncol, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[2] Liaocheng Peoples Hosp, Dept Oncol, Liaocheng, Shandong, Peoples R China
[3] Liaocheng Peoples Hosp, Dept Obstet & Gynaecol, Liaocheng, Shandong, Peoples R China
[4] Shandong Univ, Jinan, Shandong, Peoples R China
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金：
中国博士后科学基金;
关键词：
cervical cancer; immune microenvironment; immunotherapy; PD-1; TCGA;
D O I：
10.3389/fimmu.2023.1281775
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Nanotechnology in cervical cancer immunotherapy: Therapeutic vaccines and adoptive cell therapy
    Zhou, Xuyan
    Lian, Haiying
    Li, Hongpeng
    Fan, Meiling
    Xu, Wei
    Jin, Ye
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [42] Guiding treatment selection with immunotherapy compared to targeted therapy agents in patients with metastatic kidney cancer
    Rosellini, Matteo
    Marchetti, Andrea
    Tassinari, Elisa
    Nuvola, Giacomo
    Rizzo, Alessandro
    Santoni, Matteo
    Mollica, Veronica
    Massari, Francesco
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2022, 7 (01): : 131 - 149
  • [43] Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy
    Zafar, Aasma
    Khan, Muhammad Jawad
    Abu, Junaid
    Naeem, Aisha
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [44] The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer
    Ju, Mingxiu
    Pan, Baoyue
    Huang, Yongwen
    Zhou, Yun
    Chen, Jieping
    Xiang, Huiling
    Xu, Shije
    Chen, Siyu
    Lan, Chunyan
    Li, Jundong
    Zheng, Min
    CANCER MEDICINE, 2024, 13 (19):
  • [45] Chemotherapy and molecular targeting therapy for recurrent cervical cancer
    Tsuda, Naotake
    Watari, Hidemichi
    Ushijima, Kimio
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (02) : 241 - 253
  • [46] Chemotherapy and molecular targeting therapy for recurrent cervical cancer
    Naotake Tsuda
    Hidemichi Watari
    Kimio Ushijima
    Chinese Journal of Cancer Research, 2016, 28 (02) : 241 - 253
  • [47] Cytotoxic and Targeted Systemic Therapy in Advanced and Recurrent Cervical Cancer: Experience from Clinical Trials
    Seol, Hyun-Joo
    Ulak, Roshani
    Ki, Kyung-Do
    Lee, Jong-Min
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 232 (04) : 269 - 276
  • [48] The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer
    Tambaro, R
    Scambia, G
    Di Maio, M
    Pisano, C
    Barletta, E
    Iaffaioli, VR
    Pignata, S
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) : 33 - 44
  • [49] Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is Hope
    Jonathan M. Lehman
    Mary E. Gwin
    Pierre P. Massion
    Current Oncology Reports, 2017, 19
  • [50] Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
    Feng Ye
    Saikat Dewanjee
    Yuehua Li
    Niraj Kumar Jha
    Zhe-Sheng Chen
    Ankush Kumar
    Tapan Vishakha
    Saurabh Kumar Behl
    Hailin Jha
    Molecular Cancer, 22
12345